Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Employer
- University College London
- University of Glasgow
- UCL;
- University of Cincinnati
- Brunel University London;
- DAAD
- DURHAM UNIVERSITY
- Max Planck Institute for Human Cognitive and Brain Sciences •
- NTNU - Norwegian University of Science and Technology
- Nature Careers
- Tallinn University of Technology
- The Belgian Nuclear Research Centre
- University of Oslo
- Vrije Universiteit Brussel (VUB)
- 4 more »
- « less
-
Field
-
-£76,244Contract TypePermanentWorking TypeHybridAvailable for SecondmentNoClosing Date03-Mar-2026JD_Param11YesJD_Param12Yes UCL is a radically different university. Founded in 1826 in the heart of London, we were
-
https://www.ucl.ac.uk/human-resources/policies/2021/jun/conditions-service-academic-staff for more information The UCL Ways of Working supports colleagues to be successful and happy at UCL through
-
2026 - 23:00 (Europe/Oslo) Country Norway Type of Contract Temporary Job Status Full-time Hours Per Week 37.5 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme
-
2026 - 00:00 (UTC) Country United Kingdom Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to
-
, administration, communications and impact activities. In particular, the post-holder will be involved in GRACE-Epi, a major new programme of work on arts and health. About you The role-holder should have previous
-
Max Planck Institute for Human Cognitive and Brain Sciences • | Leipzig, Sachsen | Germany | 1 day ago
TU Dresden or UCL may attend online. Application deadline See our website (https://imprs-coni.mpg.de/application-dates) for further information. Tuition fees per semester in EUR None Combined Master's
-
Discounted medical insurance Visit https://www.ucl.ac.uk/work-at-ucl/rewards-and-benefits to find out more. Our commitment to Equality, Diversity and Inclusion As London’s Global University, we know diversity
-
impact due to severe unwanted side-effects, likely resulting from homeostatic roles of NF-κB. Thus, despite the tremendous therapeutic promise of modulating it’s activity, NF-κB remains an important target
-
. Furthermore, in established CRC, interaction between the microbiome and immune system is thought to impact outcomes. This exciting PhD project will build on an existing highly annotated dataset of around 2600
-
) pain affects approximately 20% of the global population, however, one in three of these patients do not respond to any form of treatments that are currently available. Our failure to offer effective pain